Gencurix Inc. (KOSDAQ:229000)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,756.00
+46.00 (2.69%)
Jun 16, 2025, 3:30 PM KST

Gencurix Revenue

Gencurix had revenue of 1.44B KRW in the quarter ending September 30, 2024, with 50.03% growth. This brings the company's revenue in the last twelve months to 3.39B, up 25.69% year-over-year. In the year 2023, Gencurix had annual revenue of 2.60B with 1.60% growth.

Revenue (ttm)
3.39B
Revenue Growth
+25.69%
P/S Ratio
7.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.60B40.83M1.60%
Dec 31, 20222.56B-487.46M-16.00%
Dec 31, 20213.05B1.47B93.83%
Dec 31, 20201.57B1.44B1,050.64%
Dec 31, 2019136.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
Peptron 4.30B
Revenue Rankings